News Results

There are 985,646 News Results

Sep 5, 2017
More Than 900 Healthcare Professionals Advance Their Education and Network at the 2017 Aprima User Conference
DALLAS, Sept. 6, 2017 /PRNewswire/ --
Sep 5, 2017
OncoSec Announces Presentations at Upcoming Investment and Scientific Conferences
SAN DIEGO, Sept. 6, 2017 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that members of its leadership team will be...
Sep 5, 2017
Bio-Techne Releases A Highly Sensitive and Specific Serological Assay to Detect Zika Virus Infections
MINNEAPOLIS, Sept. 6, 2017 /PRNewswire/ -- R&D Systems®, a Bio-Techne brand, announced today the release of a new rapid, solid phase, enzyme-linked immunosorbent assay (ELISA) designed to measure anti-Zika virus...
Sep 6, 2017
Forge Therapeutics And Evotec Present Efficacy Data For LpxC Inhibitor In Urinary Tract, Lung, Thigh, And Abdominal Infection Models At ASM ESCMID 2017
SAN DIEGO, Sept. 7, 2017 /PRNewswire/ -- Forge Therapeutics, Inc., (Forge) and its strategic alliance partner Evotec AG (Evotec), announced new preclinical data today on Forge's LpxC antibiotic program at...
Sep 6, 2017
Casa Systems Expands Partner Ecosystem and Unveils New Apex(TM) Multi-Standard Outdoor Small Cell at Mobile World Congress Americas 2017
ANDOVER, Mass., Sept. 7, 2017 /PRNewswire/ -- Casa Systems, a worldwide leader in next-generation distributed and virtualized architectures in mobile, telco and cable broadband access networks, today announced interoperability with...
Sep 7, 2017
Replimune Appoints Howard L. Kaufman, M.D., FACS as Chief Medical Officer
WOBURN, Massachusetts, September 8, 2017 /PRNewswire/ -- Replimune Group Inc. announced today a key addition to its senior leadership team as it progresses its Immulytic(TM) oncolytic immunotherapy platform rapidly towards...
Sep 8, 2017
ARMO BioSciences's Phase 1b Trials Demonstrate Continued Promising Response Rates and Survival in Patients with Advanced Pancreatic Cancer, NSCLC, and RCC
REDWOOD CITY, Calif., Sept. 9, 2017 /PRNewswire/ -- ARMO BioSciences, Inc., a late-stage immuno-oncology company, today announced that clinical trial results on its lead investigational immuno-oncology drug AM0010 (pegilodecakin, PEGylated...
Sep 10, 2017
Advicenne Announces Positive Pivotal Phase III Clinical Data for ADV7103 in Adults and Children Suffering from distal Renal Tubular Acidosis (dRTA)
NÎMES, France, September 11, 2017 /PRNewswire/ -- ADV7103 could potentially be the first approved treatment for dRTA   Advicenne, a late-stage biopharmaceutical company focused on the development of paediatric-friendly therapeutics...
Sep 10, 2017
Sunflower Health Plan Achieves 95 Percent Satisfaction Rate
LENEXA, Kan., Sept. 11, 2017 /PRNewswire/ -- A third-party research company recently surveyed Sunflower Health Plan's members who receive long-term services and supports (LTSS). The results delivered last week indicated...
Sep 10, 2017
Transition Networks Launches Gigabit Ethernet PoE+ Media Converters with Small Form-Factor Pluggable Optics
MINNEAPOLIS, Sept. 11, 2017 /PRNewswire/ -- Transition Networks, Inc., a leading provider of innovative, high-value, data network integration solutions, today announced its new family of 10/100/1000 Ethernet small form-factor pluggable...
98565

Pages

1

Stories of the day

Oct 3, 2025
Blighter Wins Contract from South East Asian Military for Smart and Scalable...
Oct 3, 2025
Denmark Deploys Terma’s Integrated Counter-UAS solution Across Strategic Sites
Oct 3, 2025
BAE Systems and Forterra join forces to develop autonomous Armored Multi-...
Oct 3, 2025
Oshkosh Defense Highlights U.S. Army Modernization with $89 Million PLS A2 Award